Related Experiment Video
Updated: Jul 3, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
How much do GOLD stages reflect CT abnormalities in COPD patients?
M Pescarolo1, N Sverzellati, A Verduri
1Dipartimento di Scienze Cliniche, Sezione di Radiologia, Università di Parma, Parma, Italy. manupeschy@libero.it
La Radiologia Medica
|July 12, 2008
Summary
Computed tomography (CT) emphysema extent significantly correlates with Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages in smokers. A 31.5% emphysema cutoff may indicate clinically worsening chronic obstructive pulmonary disease (COPD).
Area of Science:
- Pulmonology
- Radiology
- Medical Imaging
Background:
- Chronic obstructive pulmonary disease (COPD) severity is typically classified using Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria, primarily based on spirometry.
- Current GOLD staging may not fully capture the impact of structural lung changes, such as emphysema, on disease severity.
- Computed tomography (CT) offers detailed visualization of pulmonary structures, including emphysema extent and airway abnormalities.
Purpose of the Study:
- To investigate the correlation between Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages and the extent of pulmonary emphysema assessed by computed tomography (CT).
- To evaluate ancillary CT features in relation to GOLD staging in stable chronic obstructive pulmonary disease (COPD) patients.
- To determine if CT-derived emphysema extent can independently predict GOLD stage.
Main Methods:
- Patients with stable chronic obstructive pulmonary disease (COPD) were classified into GOLD stages based on clinical assessment and spirometry.
- Computed tomography (CT) scans were performed and visually evaluated for the extent of pulmonary emphysema and other airway abnormalities.
- Statistical analysis, including regression modeling, was used to assess the relationship between CT findings and GOLD stages.
Main Results:
- A significant correlation was found between the extent of emphysema on CT scans and the GOLD stage in COPD patients (r² = 0.58; p < 0.001).
- Severe emphysema was prevalent in patients classified in GOLD stages III and IV.
- A CT emphysema extent cutoff value of 31.5% was identified to distinguish patients with GOLD stage III or higher.
Conclusions:
- Computed tomography (CT) assessment of emphysema extent is a significant predictor of Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage in smokers with COPD.
- While a correlation exists, varying degrees of emphysema extent can be observed within each GOLD stage.
- An emphysema extent exceeding 31.5% on CT may serve as a threshold indicating a clinically worsening chronic obstructive pulmonary disease (COPD) status.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...